低能量冲击波治疗难治性前列腺盆腔综合征6个月疗效分析

  • 打印
  • 收藏
收藏成功


打开文本图片集

An analysis of 6-month follow-up efficacy of low-intensity extracorporeal shock wave therapy for refractory prostate-pelvic syndrome

XU Xiao,LI Guizhong,DAI Xiang,WANG Jie

(Department of Urology,Beijing Jishuitan Hospital Affiliated to Capital Medical University,Beijing 100096,China)

ABSTRACT:Objective To evaluate the long-term efficacy and safety of low-intensity extracorporeal shock wave therapy (Li-ESWT) for refractory prostate-pelvic syndrome (PPS).Methods Clinical data of 173 patients with refractory PPS undergoing Li-ESWT at our hospital during Jan.2020 and Jan.2023 were retrospectively analyzed.All patients received weekly treatment for 8 consecutive weeks.Changes in the National Institutes of Health chronic prostatitis symptom index (NIH-CPSI),international prostate symptom score (IPSS),visual analog scale (VAS),and international index of erectile function-5 (IIEF-5) were compared before treatment,immediately,1,3,and 6 months after treatment.Results A total of 142 patients (82.1%) completed all follow-ups.Compared to baseline data,there was a statistically significant improvement in NIH-CPSI,IPSS,VAS,and IIEF-5 scores immediately after treatment and 1,3,and 6 months after treatment (P<0.01).No significant adverse reactions or complications were observed throughout the follow-up.At the time of treatment completion,115 patients (81.0%) had a decrease of ≥6 in NIH-CPSI; 99 patients (69.7%) had a decrease of ≥3 in IPSS; 121 patients (85.2%) had a decrease of ≥3 in VAS; 105 patients (73.9%) had an increase of ≥4 in IIEF-5.At the 6-month follow-up,patients who responded to treatment maintained satisfactory therapeutic effects.Conclusion Li-ESWT can significantly improve clinical symptoms and quality of life for patients with refractory PPS,with therapeutic effects lasting at least 6 months.

KEY WORDS:low-intensity extracorporeal shock wave therapy; prostate-pelvic syndrome; chronic prostatitis; chronic pelvic pain syndrome

摘要:目的 评估低能量冲击波治疗难治性前列腺盆腔综合征的长期疗效及安全性。(剩余7589字)

monitor